Colposcopic Assessment of Vaginal Irritation Associated with Administration of Nonoxynol-9 Vaginal Contraceptive Film Compared to a Vaginal Contraceptive Suppository
Upmalis, D.; Creinin, M.
Fertility and Sterility 74(3): S71-S72
2000
ISSN/ISBN: 0015-0282 Document Number: 323619
Document emailed within 1 workday
Related Documents
Arambasić, M.B.; Zlatković, V.; Dimitrijević, R.; Ilić, N. 2002: Biological and chemical quality control of spermicidal raw material nonoxynol-9 and nonoxynol-9 containing vaginal contraceptive (ABF contraceptive film): determination of spermicidal activity and assay of nonoxynol-9 Bollettino Chimico Farmaceutico 141(5): 343-347Arambasić, M.B.; Zlatković, V.; Dimitrijević, R.; Ilić, N. 2002: Biological and chemical quality control of spermicidal raw material nonoxynol-9 and nonoxynol-9 containing vaginal contraceptive (ABF contraceptive film): determination of spermicidal activity and assay of nonoxynol-9 Bollettino Chimico Farmaceutico 141(5): 343-347
Arambasić, M.B.; Zlatković, V.; Dimitrijević, R.; Ilić, N. 2002: Biological and chemical quality control of spermicidal raw material nonoxynol-9 and nonoxynol-9 containing vaginal contraceptive (ABF contraceptive film): determination of spermicidal activity and assay of nonoxynol-9 Bollettino Chimico Farmaceutico 141(5): 343-347
Mauck, C.K.; Allen, S.; Baker, J.M.; Barr, S.P.; Abercrombie, T.; Archer, D.F. 1997: An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9 Contraception 56(2): 103-110
Jensen, J.T.; Archer, D.F.; Westhoff, C.L.; Nelson, A.L.; Graham, S.; Bernick, B. 2023: Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users Journal of Women's Health 32(7): 808-815
Singh, B.; Cutler, J.C.; Utidjian, H.M. 1972: Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. II. Effect in vitro of vaginal contraceptive and non-contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae British Journal of Venereal Diseases 48(1): 57-64
Xie, W.Y. 1989: Morrhuic acid vaginal contraceptive suppository Sheng Zhi Yu Bi Yun 9(4): 39-43
Mayersak, J.S.; Viviano, C.J. 1994: Transurethral insertion of a vaginal contraceptive suppository into the urinary bladder Wisconsin Medical Journal 93(1): 13-15
Camacho, D.P.; Consolaro, M.ár.E.L.; Patussi, E.V.ér.; Donatti, L.él.; Gasparetto, A.é; Svidzinski, T.I.E. 2007: Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR) Contraception 76(6): 439-443
Serati, M.; Bogani, G.; Di Dedda, M.C.; Braghiroli, A.; Uccella, S.; Cromi, A.; Ghezzi, F. 2015: A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive European Journal of Obstetrics Gynecology and Reproductive Biology 191: 48-50
Lete, I.ña.; Cuesta, M.ía.C.; Marín, J.M.; Guerra, S. 2013: Vaginal health in contraceptive vaginal ring users - a review European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(4): 234-241
Mauck, C.K.; Baker, J.M.; Barr, S.P.; Johanson, W.M.; Archer, D.F. 1997: A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy Contraception 56(2): 97-102
Joshi, S.; Joglekar, N.; Ghate, M.; Unni, J.; Risbud, A.; Bentley, M.; Shepherd, M.; Bollinger, R.; Mehendale, S. 2003: Phase i safety and preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India Indian Journal of Medical Research 117: 152-157
Mauck, C.K.; Baker, J.M.; Barr, S.P.; Abercrombie, T.J.; Archer, D.F. 1997: A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy Contraception 56(2): 89-96
2012: Vaginal atrophy. Managing vaginal dryness and irritation Mayo Clinic Health Letter 30(10): 6
Mayersak, J.S.; Viviano, C.J. 1993: Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management Journal of Urology 149(4): 835-837
Le Lannou, D.; Colleu, D.; Blanchard, D. 1988: Effets in vitro d'un spermicide vaginal, le nonoxynol 9 ou Patentex ovule - In vitro effects of vaginal spermicid: nonoxynol 9 or Patentex Contraception Fertilite Sexualite (1973) 16(1): 20-22
Souka, A.R.; el Sokkary, H.; Kamel, M.; Hassan, M. 1986: The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation Contraception 33(4): 365-371
Barnhart, K.; Pretorius, E.Scott.; Marunich, R.; Hummel, A. 2004: Vaginal distribution of miconazole nitrate suspension from administration of a single vaginal insert Journal of Reproductive Medicine 49(2): 83-88
Digesu, G.Alessandro.; Tailor, V.; Preti, M.; Vieira-Baptista, P.; Tarcan, T.; Stockdale, C.; Mourad, S. 2019: The energy based devices for vaginal "rejuvenation," urinary incontinence, vaginal cosmetic procedures, and other vulvo-vaginal disorders: An international multidisciplinary expert panel opinion Neurourology and Urodynamics 38(3): 1005-1008